Press Releases

Key HighlightsCannPal has completed its evaluation into the microencapsulation of hemp-derived oils with the Commonwealth Scientific and Industrial Research Organisation (CSIRO); CSIRO has granted CannPal an exclusive global licence to commercialise their patented MicroMAX® microencapsulation technology in the field of Animal Therapeutics; Developed through extensive research and

TORONTO and HOUSTON, Jan. 8, 2020 /PRNewswire/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA; OTCQB: MDNAF), a clinical stage immuno-oncology company, announced today that it has received $1,345,871 from the early exercise of previously issued warrants. A total of 855,621 warra

TEL AVIV, Israel, Jan. 8, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (Nasdaq: APOP) ("Cellect" or the "Company"), a developer of innovative technology which enables the functional selection of stem cells, today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,000,000 America

NORTH READING, Mass., Jan. 8, 2020 /PRNewswire/ -- TraceLink Inc., a network-based platform company with the world's largest integrated digital supply network for life sciences, today announced tha

PARK CITY, Utah, Jan. 8, 2020 /PRNewswire/ -- ZAND, the #1 natural lozenge brand in health food stores — known for herbal-based immune support — has announced the launch of the brand's first rapid immunity product, Immune Fast. This breakthrough new supplement delivers clinically supported immune support within two hours1 — whenev

STOCKHOLM, Jan. 8, 2020 /PRNewswire/ -- SyntheticMR announced today at the American Society of Pediatric Neuroradiology (ASPNR) the clinical use of their novel MR quantification solution, SyMRI, at Cincinnati Children's Hospital Medical Center, for pediatric cases requiring cerebrospinal fluid measurements - a

OCEANSIDE, California, Jan. 8, 2020 /PRNewswire/ -- Therapeutics Solutions International, Inc., (OTC Markets: TSOI) reported today positive animal and human brain cell data demonstrating inhibition in microglial activation of IL-1 beta, IL-6, and TNF-a. NeuroStilbene was also shown to induce neurogenic growth factors and protected from peroxide and kainic-acid induced ap

SAN DIEGO, Jan. 8, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable information t

IRVINE, Calif., Jan. 8, 2020 /PRNewswire/ -- Tarsus Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced the completion of $60 million in Series B financing.  The financing was led by Vivo Capital and included Frazier Healthcare Partners, Flying L Partners, Visionary Ventures, Aperture Venture Partners, and

SAN DIEGO, Jan. 8, 2020 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, announced today that ViaCyte's President and CEO Paul Laikind,